nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An immunotherapeutic approach to treatment of breast cancer: focus on trastuzumab plus paclitaxel
|
Gilewski, Teresa |
|
2000 |
46 |
1 |
p. S23-S26 |
artikel |
2 |
A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism
|
Matsuba, Y. |
|
2000 |
46 |
1 |
p. 1-9 |
artikel |
3 |
A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility
|
Sirotnak, F. M. |
|
2000 |
46 |
1 |
p. 79-83 |
artikel |
4 |
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
|
Nelson, William G. |
|
2000 |
46 |
1 |
p. S67-S72 |
artikel |
5 |
Cancer immunotherapy in clinical oncology
|
Knuth, Alexander |
|
2000 |
46 |
1 |
p. S46-S51 |
artikel |
6 |
Development of a cancer vaccine: peptides, proteins, and DNA
|
Shiku, Hiroshi |
|
2000 |
46 |
1 |
p. S77-S82 |
artikel |
7 |
Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer
|
Murren, John R. |
|
2000 |
46 |
1 |
p. 43-50 |
artikel |
8 |
Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women
|
Dowsett, Mitchell |
|
2000 |
46 |
1 |
p. 35-39 |
artikel |
9 |
Erratum: Cancer Chemother Pharmacol 45:345–349
|
, |
|
2000 |
46 |
1 |
p. 84 |
artikel |
10 |
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine
|
Braybrooke, Jeremy P. |
|
2000 |
46 |
1 |
p. 27-34 |
artikel |
11 |
Exploitation of the B cell repertoire for the identification of human tumor antigens
|
Pfreundschuh, Michael |
|
2000 |
46 |
1 |
p. S3-S7 |
artikel |
12 |
Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy
|
Westermann, Anneke M. |
|
2000 |
46 |
1 |
p. 57-62 |
artikel |
13 |
Human CD8 and CD4 T cell epitopes of epithelial cancer antigens
|
Sato, Noriyuki |
|
2000 |
46 |
1 |
p. S86-S90 |
artikel |
14 |
Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease
|
da Costa, Ligia |
|
2000 |
46 |
1 |
p. S33-S36 |
artikel |
15 |
Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats
|
Fuskevåg, Ole-Martin |
|
2000 |
46 |
1 |
p. 69-73 |
artikel |
16 |
Melanoma vaccines: the paradox of T cell activation without clinical response
|
Nielsen, Mai-Britt |
|
2000 |
46 |
1 |
p. S62-S66 |
artikel |
17 |
Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer
|
Sakamoto, Junichi |
|
2000 |
46 |
1 |
p. S27-S32 |
artikel |
18 |
Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours
|
Harrington, Kevin J. |
|
2000 |
46 |
1 |
p. 10-18 |
artikel |
19 |
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis
|
Tetef, Merry L. |
|
2000 |
46 |
1 |
p. 19-26 |
artikel |
20 |
Pharmacokinetics of 2-chloro-2′-deoxyadenosine administered subcutaneously or by continuous intravenous infusion
|
Sonderegger, Theodor |
|
2000 |
46 |
1 |
p. 40-42 |
artikel |
21 |
Preface
|
Saito, Hidehiko |
|
2000 |
46 |
1 |
p. S1 |
artikel |
22 |
Primary treatment of low-grade non-Hodgkin's lymphoma using an all oral anthracycline-containing regimen, chlorambucil, idarubicin, dexamethasone (CID) – a phase II study
|
Taylor, Penelope |
|
2000 |
46 |
1 |
p. 63-68 |
artikel |
23 |
Problems in the development of target-based drugs
|
Saijo, Nagahiro |
|
2000 |
46 |
1 |
p. S43-S45 |
artikel |
24 |
Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells
|
Tani, Kenzaburo |
|
2000 |
46 |
1 |
p. S73-S76 |
artikel |
25 |
Recombinant antibodies against ganglioside expressed on tumor cells
|
Hanai, Nobuo |
|
2000 |
46 |
1 |
p. S13-S17 |
artikel |
26 |
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer
|
Chester, Kerry A. |
|
2000 |
46 |
1 |
p. S8-S12 |
artikel |
27 |
Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats
|
Yoshisue, Kunihiro |
|
2000 |
46 |
1 |
p. 51-56 |
artikel |
28 |
Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo
|
Caffrey, Paula B. |
|
2000 |
46 |
1 |
p. 74-78 |
artikel |
29 |
SEREX analysis of gastric cancer antigens
|
Obata, Yuichi |
|
2000 |
46 |
1 |
p. S37-S42 |
artikel |
30 |
Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates
|
Sievers, Eric L. |
|
2000 |
46 |
1 |
p. S18-S22 |
artikel |
31 |
The critical role of Th1-dominant immunity in tumor immunology
|
Nishimura, Takashi |
|
2000 |
46 |
1 |
p. S52-S61 |
artikel |
32 |
Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients
|
Cerundolo, Vincenzo |
|
2000 |
46 |
1 |
p. S83-S85 |
artikel |